Search Results - "LADERO, J. M"

Refine Results
  1. 1

    Leflunomide-induced acute hepatitis by Sevilla-Mantilla, C., Ortega, L., Agúndez, J.A.G., Fernández-Gutiérrez, B., Ladero, J.M., Dı́az-Rubio, M.

    Published in Digestive and liver disease (2004)
    “…Leflunomide, a new immunomodulatory agent, was prescribed to a 67-year-old female patient with rheumatoid arthritis. Fifteen days later she developed diarrhoea…”
    Get full text
    Journal Article
  2. 2

    Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk by AGUNDEZ, J. A. G, MARTINEZ, C, OLIVERA, M, GALLARDO, L, LADERO, J. M, ROSADO, C, PRADOS, J, RODRIGUEZ-MOLINA, J, RESEL, L, BENITEZ, J

    Published in British journal of cancer (01-11-1998)
    “…The role of two common polymorphisms of enzymes involved in the metabolism of drugs and carcinogens was studied in relation to prostate cancer. The gene…”
    Get full text
    Journal Article
  3. 3

    Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population by Agúndez, J A, Ledesma, M C, Ladero, J M, Benítez, J

    Published in Clinical pharmacology and therapeutics (01-03-1995)
    “…The occurrence of multiple copies of the CYP2D6 gene was investigated 217 white healthy Spaniards by the combined use of Xba I and Eco RI restriction fragment…”
    Get more information
    Journal Article
  4. 4

    Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs by Ladero, J M

    Published in Current drug metabolism (01-07-2008)
    “…Polymorphic N-acetyl transferases (NAT) 1 and 2 are involved in detoxification of xenobiotic arylamines and hydralazines. These common environmental chemicals…”
    Get more information
    Journal Article
  5. 5

    High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population by GARCIA-MARTIN, Elena, MARTINEZ, Carmen, LADERO, José M, GAMITO, Francisco J. G, AGUNDEZ, José A. G

    Published in European journal of clinical pharmacology (01-04-2001)
    “…To search for ethnic variability in the impact of cytochrome P450 2C9 (CYP2C9) polymorphism. CYP2C9 allelic variants related to impaired CYP2C9 metabolism were…”
    Get full text
    Journal Article
  6. 6

    Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease by AGUNDEZ, J. A. G, JIMENEZ-JIMENEZ, F. J, ALVAREZ-CERMENO, J. C, BENITEZ, J, LUENGO, A, MOLINA, J. A, ORTI-PAREJA, M, VAZQUEZ, A, RAMOS, F, DUARTE, J, CORIA, F, LADERO, J. M

    Published in Neurology (01-12-1998)
    “…To determine the frequency and the linkage distribution of seven mutations at the polymorphic gene coding for the arylamine N-acetyl transferase (NAT2; EC…”
    Get full text
    Journal Article
  7. 7

    RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma by Ladero, J M, Agúndez, J A, Rodríguez-Lescure, A, Diaz-Rubio, M, Benítez, J

    Published in Gut (01-08-1996)
    “…BACKGROUND: CYP2E1, the coding gene for the ethanol inducible cytochrome P4502E1, is polymorphic at the RsaI restriction site in the 5' flanking region. The…”
    Get full text
    Journal Article
  8. 8

    N-Acetyltransferase 2 (NAT2) Genotype and Colorectal Carcinoma: Risk Variability According to Tumour Site? by AGUNDEZ, J. A. G, LOZANO, L, LADERO, J. M, SASTRE, J, CERDAN, F. J, DIAZ-RUBIO, M, BENITEZ, J

    “…Background: Dietary heterocyclic aromatic amines (HAAs) are members of a family of chemicals that comprise highly mutagenic compounds related to colon cancer…”
    Get full text
    Journal Article
  9. 9

    CYP2D6 genes and risk of liver cancer by Agúndez, J A, Ledesma, M C, Benítez, J, Ladero, J M, Rodríguez-Lescure, A, Díaz-Rubio, E, Díaz-Rubio, M

    Published in The Lancet (British edition) (01-04-1995)
    “…We have studied by use of PCR and XbaI and EcoRI restriction-fragment-length polymorphism whether mutations at the polymorphic CYP2D6 (debrisoquine…”
    Get more information
    Journal Article
  10. 10

    N -Acetyltransferase 2 Polymorphism Is Not Related to the Risk of Advanced Alcoholic Liver Disease by Agúndez, J. A. G., Ladero, J. M., Olivera, M., Lozano, L., Fernández-Arquero, M., Concha, E. G. de la, Díaz-Rubio, M., Benítez, J.

    “…Background: Ethanol abuse is the most prevalent cause of liver cirrhosis in Spain. Genetic polymorphisms affect the activity of the enzymes involved in ethanol…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hereditary hyperferritinemia-cataract syndrome. Study of a new family in Spain by Ladero, J M, Balas, A, García-Sánchez, F, Vicario, J L, Díaz-Rubio, M

    “…The hyperferritinemia-cataract syndrome, inherited as a Mendelian dominant trait, is due to mutations in the 5' non-coding region of the ferritin light chain…”
    Get full text
    Journal Article
  13. 13

    Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use by Martínez, Carmen, Blanco, Gerardo, Ladero, José M, García‐Martín, Elena, Taxonera, Carlos, Gamito, Francisco G, Diaz‐Rubio, Manuel, Agúndez, José A G

    Published in British journal of pharmacology (01-01-2004)
    “…Impaired drug metabolism is a major cause of adverse drug reactions, and it is often caused by mutations at genes coding for drug‐metabolising enzymes. Two…”
    Get full text
    Journal Article
  14. 14

    Acetylator polymorphism in human colorectal carcinoma by LADERO, J. M, GONZALEZ, J. F, BENITEZ, J, VARGAS, E, FERNANDEZ, M. J, BAKI, W, DIAZ-RUBIO, M

    Published in Cancer research (Chicago, Ill.) (15-04-1991)
    “…Acetylator phenotype has been determined using sulfamethazine in 109 patients histologically diagnosed with colorectal carcinoma (resected in 74 patients by…”
    Get full text
    Journal Article
  15. 15

    The Role of Sonography in the Early Diagnosis of Biliopancreatic Ascaris Infestation by Larrubia, J R, Ladero, J M, Mendoza, J L, Morillas, J D, Diaz-Rubio, M

    Published in Journal of clinical gastroenterology (01-01-1996)
    “…Acute pancreatitis due to ascaris lumbricoides infestation is extraordinarily uncommon in Europe. The diagnosis can be difficult because of the low index of…”
    Get full text
    Journal Article
  16. 16

    Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population by Agúndez, J A, Martínez, C, Olivera, M, Ledesma, M C, Ladero, J M, Benítez, J

    Published in Clinical pharmacology and therapeutics (01-08-1994)
    “…The arylamine N-acetyltransferase (NAT-2) polymorphism causes impaired drug metabolism in about half of the white population. By the combined use of polymerase…”
    Get more information
    Journal Article
  17. 17

    Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients by Agúndez, J A, Ladero, J M, Olivera, M, Abildúa, R, Román, J M, Benítez, J

    Published in Oncology (01-01-1995)
    “…The association of the arylamine N-acetyltransferase polymorphism and breast cancer has been investigated by analysis of genomic DNA from 160 breast cancer…”
    Get more information
    Journal Article
  18. 18

    Oxidative polymorphism of debrisoquine in Parkinson's disease by Benitez, J, Ladero, J M, Jimenez-Jimenez, F J, Martinez, C, Puerto, A M, Valdivielso, M J, Llerena, A, Cobaleda, J, Muñoz, J J

    “…Oxidative phenotype and metabolic ratio (MR) of debrisoquine (DBQ) have been determined in 87 patients with Parkinson's disease and in 556 healthy control…”
    Get full text
    Journal Article
  19. 19
  20. 20

    CYP2D6 genotypes in Spanish women with breast cancer by Ladona, Margarita G., Abildúa, Rosa E., Ladero, JoséM., Román, JoséM., Plaza, María A., Agúndez, JoséA.G., Muñoz, Juan J., Beníez, Julio

    Published in Cancer letters (19-01-1996)
    “…Wild type and three mutated alleles of the polymorphic CYP2D6 gene were studied in genomic DNA samples from 187 women with breast carcinoma and 151 healthy…”
    Get full text
    Journal Article